Position in DHR
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$631,821
-$100,792 QoQ
Shares Held
3,317
-14.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,250
of 2,098 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026LRI Investments, LLC holds $6,589,239 across 23 Diagnostics & Research names. DHR ranks #2 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
23,909 | $4,619,696 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
3,317 | $631,821 | |
| 3 | NTRA |
Natera, Inc.
|
1,596 | $433,234 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
757 | $379,529 | |
| 5 | DGX |
Quest Diagnostics Inc
|
1,026 | $217,460 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
186 | $98,503 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
146 | $76,859 | |
| 8 | WGS |
GeneDx Holdings Corp.
|
837 | $57,460 |
All Filings in DHR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $631,821 | 3,317 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $732,613 | 3,864 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $829,833 | 3,625 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $726,423 | 3,664 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $860,088 | 4,354 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $872,890 | 4,258 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $1,015,988 | 4,426 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,263,600 | 4,545 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $622,125 | 2,490 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $170,059 | 681 | Shares | Sole | 2024-05-21 | |
| No filing history on record for this holder in this stock. | ||||||